Brief: Cantargia Reports Positive Results On Biomarkers, Safety In CAN10 Phase 1 Clinical Study
Oct 11 (Reuters) - Cantargia AB CANTA.ST :
* CANTARGIA REPORTS NEW POSITIVE RESULTS ON BIOMARKERS AND
SAFETY
IN CAN10 PHASE 1 CLINICAL STUDY
Source text for Eikon: ID:nMFNbrj3S
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))